Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-06
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥2.7bn2024-04-01 → 2024-09-30StandaloneNet sales
Revenue¥5.1bn2023-04-01 → 2024-03-31StandaloneNet sales (5-year summary)
Revenue¥2.5bn2023-04-01 → 2023-09-30StandaloneNet sales
Operating income¥471m2024-04-01 → 2024-09-30StandaloneOperating income
Operating income¥518m2023-04-01 → 2023-09-30StandaloneOperating income
Ordinary income¥474m2024-04-01 → 2024-09-30StandaloneOrdinary income
Ordinary income¥929m2023-04-01 → 2024-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥525m2023-04-01 → 2023-09-30StandaloneOrdinary income
Profit before tax¥474m2024-04-01 → 2024-09-30StandaloneIncome before income taxes
Profit before tax¥528m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Net income¥348m2024-04-01 → 2024-09-30StandaloneProfit loss
Net income¥638m2023-04-01 → 2024-03-31StandaloneNet income loss (5-year summary)
Net income¥370m2023-04-01 → 2023-09-30StandaloneProfit loss
Total assets¥8.4bnat 2024-09-30StandaloneAssets
Total assets¥8.6bnat 2024-03-31StandaloneAssets
Total assets¥8.1bnat 2023-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥2.0bnat 2024-09-30StandaloneLiabilities
Total liabilities¥2.3bnat 2024-03-31StandaloneLiabilities
Net assets / equity¥6.5bnat 2024-09-30StandaloneNet assets
Net assets / equity¥6.3bnat 2024-03-31StandaloneNet assets
Net assets / equity¥6.0bnat 2023-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥3.1bnat 2024-09-30StandaloneCash and deposits
Cash and deposits¥3.2bnat 2024-03-31StandaloneCash and deposits
Cash & equivalents¥2.8bnat 2024-09-30StandaloneCash and cash equivalents
Cash & equivalents¥2.8bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥2.4bnat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥2.7bnat 2023-03-31dStandaloneCash and cash equivalents
Operating cash flow¥346m2024-04-01 → 2024-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥431m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥17m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥12m2024-04-01 → 2024-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥73m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥66m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥397m2024-04-01 → 2024-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥204m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥182m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥82.542024-04-01 → 2024-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥152.262023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥88.662023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥322023-04-01 → 2024-03-31StandaloneDividend paid per share (5-year summary)
Equity ratio76.6%at 2024-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio72.9%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio73.2%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued4,558,860at 2024-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued4,558,860at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,558,860at 2023-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 393
ItemContextValueUnit
Address major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)東京都文京区本郷二丁目38番18号
Name major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)株式会社エスアイエル
Address major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)東京都豊島区南池袋二丁目9番9号
Name major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)上地 桂子
Address major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)東京都葛飾区
Name major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)日本化薬株式会社
Address major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)東京都千代田区丸の内二丁目1番1号
Name major shareholdersCurrentQuarterInstant_No11MajorShareholdersMember
Original text (Japanese)株式会社商工組合中央金庫
Address major shareholdersCurrentQuarterInstant_No11MajorShareholdersMember
Original text (Japanese)東京都中央区八重洲二丁目10番17号
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember
Original text (Japanese)単元株式数100株
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsOtherMember
Original text (Japanese)同上
Description issued shares voting rightsCurrentQuarterInstant_SharesLessThanOneUnitMember-
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)株式会社カイノス
Address of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)東京都文京区本郷二丁目38番18号
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which financial statements have been prepared financial informationCurrentYTDDurationText · Plus
Type1 semi annual financial statements financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Description of fact that consolidated financial statements have not been prepared financial informationCurrentYTDDuration
Original text (Japanese) 当社は子会社がありませんので、中間連結財務諸表を作成しておりません。
Quarterly balance sheet (text)CurrentYTDDurationText · Plus
Year to quarter end statement of income (text)CurrentYTDDurationText · Plus
Quarterly statement of cash flows (text)CurrentYTDDurationText · Plus
Notes additional information quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes regarding promissory notes due on balance sheet date (text)CurrentQuarterInstant_NonConsolidatedMemberText · Plus
Major components of selling general and administrative expenses (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Notes regarding dividend (text)Prior1YTDDuration_NonConsolidatedMemberText · Plus
Notes regarding dividend (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Notes financial instruments quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes securities quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes derivatives quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes segment information etc quarterly financial statements (text)CurrentYTDDurationText · Plus
Description of fact that companys business comprises single segmentCurrentYTDDuration_NonConsolidatedMember
Original text (Japanese)     当社は、臨床検査薬の製造及び販売事業の単一セグメントであるため、記載を省略しております。
Notes revenue recognition quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly financial statements (text)CurrentYTDDurationText · Plus
Other information financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2024-03-31pass
balance sheet identitynon_consolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2024-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2024-04-01/2024-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2024-09-30pass